Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) appointed Mr. Charles Rowland MBA, CPA, as its Chief Executive Officer replacing Mr. Stephen Zaruby ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE